MassBio Lunch and Learn
IVAL Contract Research Service: In vitro screening for human-specific adverse drug properties
Speaker: Albert P. Li, PhD, President and CEO of IVAL
Clinical trial failure is a major challenge for drug development. Reasons for the failures are unexpected adverse drug properties that, due to species difference, are not detected in nonclinical testing in laboratory animals. In the past decade, IVAL has developed highly accurate and rapid screening assays for human-specific adverse drug properties using high quality primary human hepatocytes and enterocytes. The assays require minimum test materials
Date: Tuesday March 27th
Time: 12:00 PM – 13:00 PM
Location: MassBio, Collaboration Room, 300 Technology Square, 8th Floor, Cambridge MA 02139
The symposium is free to all attendees. Enjoy FREE lunch while learning about IVAL’s service offerings.